The pharmacology and toxicology of three new biologic agents used in pulmonary medicine

Timothy E Albertson, William F. Walby, Roblee P Allen, R. Steven Tharratt

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Biological agents have played an important role in the evolution of modern medical therapeutics. Recent advances in biologicals have in part been stimulated by the biotechnology revolution seen over the last several years. Toxicologists need to be aware of the proposed mechanisms and approved and experimental uses of these new biologic agents. Further, controversies about their use, efficacy, cost issues and potential toxicities should be known. Often these drugs are designed for small patient populations thus limiting the availability of human toxicological data bases. This paper reviews the pharmacology and toxicology of three new biologies (recombinant human DNase I, alpha 1-protease inhibitor, and nitric oxide). These agents appear to have important roles in treating specific diseases or disease states seen in pulmonary medicine.

Original languageEnglish (US)
Pages (from-to)427-438
Number of pages12
JournalClinical Toxicology
Volume33
Issue number5
DOIs
StatePublished - 1995

Fingerprint

Pulmonary Medicine
Biological Factors
Toxicology
Medicine
Pharmacology
alpha 1-Antitrypsin
Deoxyribonuclease I
Biotechnology
Toxicity
Nitric Oxide
Availability
Databases
Costs and Cost Analysis
Pharmaceutical Preparations
Population
Costs
Therapeutics
dornase alfa

Keywords

  • Alpha 1-antitrypsin
  • Alpha 1-protease inhibitor
  • Deoxvribnonuclease I
  • DNA. Recombinant
  • Dornase. Alpha
  • Nitric oxide
  • RhDNase

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

The pharmacology and toxicology of three new biologic agents used in pulmonary medicine. / Albertson, Timothy E; Walby, William F.; Allen, Roblee P; Tharratt, R. Steven.

In: Clinical Toxicology, Vol. 33, No. 5, 1995, p. 427-438.

Research output: Contribution to journalArticle

@article{6225816589dd40dd8a4588998b6e6bf0,
title = "The pharmacology and toxicology of three new biologic agents used in pulmonary medicine",
abstract = "Biological agents have played an important role in the evolution of modern medical therapeutics. Recent advances in biologicals have in part been stimulated by the biotechnology revolution seen over the last several years. Toxicologists need to be aware of the proposed mechanisms and approved and experimental uses of these new biologic agents. Further, controversies about their use, efficacy, cost issues and potential toxicities should be known. Often these drugs are designed for small patient populations thus limiting the availability of human toxicological data bases. This paper reviews the pharmacology and toxicology of three new biologies (recombinant human DNase I, alpha 1-protease inhibitor, and nitric oxide). These agents appear to have important roles in treating specific diseases or disease states seen in pulmonary medicine.",
keywords = "Alpha 1-antitrypsin, Alpha 1-protease inhibitor, Deoxvribnonuclease I, DNA. Recombinant, Dornase. Alpha, Nitric oxide, RhDNase",
author = "Albertson, {Timothy E} and Walby, {William F.} and Allen, {Roblee P} and Tharratt, {R. Steven}",
year = "1995",
doi = "10.3109/15563659509013751",
language = "English (US)",
volume = "33",
pages = "427--438",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - The pharmacology and toxicology of three new biologic agents used in pulmonary medicine

AU - Albertson, Timothy E

AU - Walby, William F.

AU - Allen, Roblee P

AU - Tharratt, R. Steven

PY - 1995

Y1 - 1995

N2 - Biological agents have played an important role in the evolution of modern medical therapeutics. Recent advances in biologicals have in part been stimulated by the biotechnology revolution seen over the last several years. Toxicologists need to be aware of the proposed mechanisms and approved and experimental uses of these new biologic agents. Further, controversies about their use, efficacy, cost issues and potential toxicities should be known. Often these drugs are designed for small patient populations thus limiting the availability of human toxicological data bases. This paper reviews the pharmacology and toxicology of three new biologies (recombinant human DNase I, alpha 1-protease inhibitor, and nitric oxide). These agents appear to have important roles in treating specific diseases or disease states seen in pulmonary medicine.

AB - Biological agents have played an important role in the evolution of modern medical therapeutics. Recent advances in biologicals have in part been stimulated by the biotechnology revolution seen over the last several years. Toxicologists need to be aware of the proposed mechanisms and approved and experimental uses of these new biologic agents. Further, controversies about their use, efficacy, cost issues and potential toxicities should be known. Often these drugs are designed for small patient populations thus limiting the availability of human toxicological data bases. This paper reviews the pharmacology and toxicology of three new biologies (recombinant human DNase I, alpha 1-protease inhibitor, and nitric oxide). These agents appear to have important roles in treating specific diseases or disease states seen in pulmonary medicine.

KW - Alpha 1-antitrypsin

KW - Alpha 1-protease inhibitor

KW - Deoxvribnonuclease I

KW - DNA. Recombinant

KW - Dornase. Alpha

KW - Nitric oxide

KW - RhDNase

UR - http://www.scopus.com/inward/record.url?scp=0029151073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029151073&partnerID=8YFLogxK

U2 - 10.3109/15563659509013751

DO - 10.3109/15563659509013751

M3 - Article

C2 - 7650767

AN - SCOPUS:0029151073

VL - 33

SP - 427

EP - 438

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 5

ER -